Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Perspective Therapeutics, Inc. (CATX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Perspective Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 728387.
Total stock buying since 2015: $59,573,990.
Total stock sales since 2015: $20,410.
Total stock option exercises since 2015: $499,591.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 70,649 | $151,650 | 0 | $0 | 0 | $0 |
| 2024 | 61,301,323 | $58,357,890 | 0 | $0 | 30,000 | $10,800 |
| 2023 | 747,768 | $229,536 | 0 | $0 | 187,500 | $114,374 |
| 2022 | 718,204 | $238,752 | 0 | $0 | 22,500 | $7,425 |
| 2021 | 0 | $0 | 0 | $0 | 337,500 | $167,400 |
| 2020 | 297,608 | $144,960 | 0 | $0 | 262,500 | $130,725 |
| 2019 | 210,000 | $82,650 | 0 | $0 | 21,900 | $5,694 |
| 2018 | 261,735 | $107,499 | 0 | $0 | 0 | $0 |
| 2017 | 134,265 | $68,055 | 0 | $0 | 82,810 | $50,100 |
| 2016 | 122,000 | $96,425 | 0 | $0 | 0 | $0 |
| 2015 | 65,029 | $96,573 | 13,340 | $20,410 | 13,340 | $13,073 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-11 | 20,498 | $42,242 | 0 | $0 | 0 | $0 |
| 2025-03 | 50,151 | $109,408 | 0 | $0 | 0 | $0 |
| 2024-12 | 33,975 | $130,139 | 0 | $0 | 0 | $0 |
| 2024-11 | 45,595 | $171,412 | 0 | $0 | 0 | $0 |
| 2024-06 | 140,633 | $234,834 | 0 | $0 | 0 | $0 |
| 2024-05 | 55,000 | $75,900 | 0 | $0 | 0 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 30,000 | $10,800 |
| 2024-03 | 60,431,039 | $57,409,487 | 0 | $0 | 0 | $0 |
| 2024-01 | 595,081 | $336,118 | 0 | $0 | 0 | $0 |
| 2023-12 | 747,768 | $229,536 | 0 | $0 | 0 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 187,500 | $114,374 |
| 2022-12 | 85,404 | $32,506 | 0 | $0 | 0 | $0 |
| 2022-11 | 500,000 | $167,500 | 0 | $0 | 0 | $0 |
| 2022-08 | 0 | $0 | 0 | $0 | 22,500 | $7,425 |
| 2022-06 | 132,800 | $38,746 | 0 | $0 | 0 | $0 |
| 2021-11 | 0 | $0 | 0 | $0 | 125,000 | $55,625 |
| 2021-03 | 0 | $0 | 0 | $0 | 212,500 | $111,775 |
| 2020-11 | 68,000 | $25,568 | 0 | $0 | 0 | $0 |
| 2020-10 | 229,608 | $119,392 | 0 | $0 | 0 | $0 |
| 2020-02 | 0 | $0 | 0 | $0 | 262,500 | $130,725 |
| 2019-11 | 210,000 | $82,650 | 0 | $0 | 0 | $0 |
| 2019-05 | 0 | $0 | 0 | $0 | 21,900 | $5,694 |
| 2018-11 | 201,735 | $81,349 | 0 | $0 | 0 | $0 |
| 2018-03 | 60,000 | $26,150 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-13 | Hunt Jonathan Robert (Chief Accounting Officer) | Buy | 11,000 | 2.03 | 22,297 |
| 2025-11-12 | Williamson Robert F Iii | Buy | 9,498 | 2.10 | 19,945 |
| 2025-03-31 | Woods Lori A | Buy | 23,475 | 2.13 | 50,001 |
| 2025-03-28 | Spoor Johan M. (Chief Executive Officer) | Buy | 26,676 | 2.23 | 59,407 |
| 2024-12-04 | Spoor Johan M. (CEO) | Buy | 8,000 | 3.77 | 30,136 |
| 2024-12-04 | Henson Heidi | Buy | 25,975 | 3.85 | 100,003 |
| 2024-11-25 | Spoor Johan M. (CEO) | Buy | 26,500 | 3.79 | 100,567 |
| 2024-11-25 | Williamson Robert F Iii | Buy | 6,266 | 3.65 | 22,839 |
| 2024-11-25 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 12,829 | 3.74 | 48,006 |
| 2024-06-17 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 1,800 | 9.81 | 17,667 |
| 2024-06-14 | Woods Lori A | Buy | 4,587 | 10.85 | 49,768 |
| 2024-06-13 | Spoor Johan M. (CEO) | Buy | 100,000 | 1.17 | 117,400 |
| 2024-06-03 | Woods Lori A | Buy | 34,246 | 1.46 | 49,999 |
| 2024-05-31 | Williamson Robert F Iii | Buy | 55,000 | 1.38 | 75,900 |
| 2024-04-23 | Austin Mark John (VP Finance/Prin Fin&Acct Offic) | Option Ex | 30,000 | .36 | 10,800 |
| 2024-03-06 | Lantheus Holdings, Inc. | Buy | 60,431,039 | .95 | 57,409,487 |
| 2024-01-30 | Williamson Robert F Iii (Director) | Buy | 127,206 | .71 | 90,316 |
| 2024-01-29 | Williamson Robert F Iii (Director) | Buy | 25,266 | .64 | 16,170 |
| 2024-01-26 | Williamson Robert F Iii (Director) | Buy | 110,613 | .58 | 64,155 |
| 2024-01-25 | Williamson Robert F Iii (Director) | Buy | 22,134 | .49 | 10,845 |
| 2024-01-24 | Puhlmann Markus (Chief Medical Officer) | Buy | 280,000 | .50 | 140,000 |
| 2024-01-24 | Williamson Robert F Iii (Director) | Buy | 29,862 | .49 | 14,632 |
| 2023-12-21 | Williamson Robert F Iii (Director) | Buy | 3,663 | .33 | 1,201 |
| 2023-12-19 | Puhlmann Markus (Chief Medical Officer) | Buy | 400,000 | .34 | 137,200 |
| 2023-12-19 | Williamson Robert F Iii (Director) | Buy | 13,680 | .32 | 4,377 |
| 2023-12-18 | Puhlmann Markus (Chief Medical Officer) | Buy | 60,419 | .26 | 15,467 |
| 2023-12-18 | Williamson Robert F Iii (Director) | Buy | 10,000 | .26 | 2,600 |
| 2023-12-18 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 125,000 | .26 | 32,375 |
| 2023-12-15 | Puhlmann Markus (Chief Medical Officer) | Buy | 135,006 | .27 | 36,316 |
| 2023-04-17 | Woods Lori A (Director) | Option Ex | 23,566 | .61 | 14,375 |
| 2023-04-13 | Woods Lori A (Director) | Option Ex | 163,934 | .61 | 99,999 |
| 2022-12-05 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 32,200 | .38 | 12,236 |
| 2022-12-01 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 53,204 | .38 | 20,270 |
| 2022-11-15 | Woods Lori A (CEO) | Buy | 300,000 | .34 | 100,500 |
| 2022-08-05 | Streeter Jennifer (COO & VP of HR) | Option Ex | 22,500 | .33 | 7,425 |
| 2022-06-09 | Austin Mark John (VP Finance/Prin Fin&Acct Offic) | Buy | 13,800 | .29 | 3,960 |
| 2022-06-08 | Austin Mark John (VP Finance/Prin Fin&Acct Offic) | Buy | 5,000 | .28 | 1,424 |
| 2022-06-08 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 25,675 | .29 | 7,445 |
| 2022-06-07 | Woods Lori A (CEO) | Buy | 75,000 | .30 | 22,200 |
| 2022-06-07 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 13,325 | .28 | 3,717 |
| 2021-11-23 | Woods Lori A (CEO) | Option Ex | 125,000 | .45 | 55,625 |
| 2021-03-12 | Woods Lori A (CEO) | Option Ex | 212,500 | .53 | 111,775 |
| 2020-11-30 | Woods Lori A (CEO) | Buy | 68,000 | .38 | 25,568 |
| 2020-10-22 | Austin Mark John (Controller/Prin Fin&Acct Offic) | Buy | 19,230 | .52 | 9,999 |
| 2020-10-22 | Krachon Michael (EVP of Sales & Marketing) | Buy | 28,844 | .52 | 14,998 |
| 2020-10-22 | Hoffmann Alan (Director) | Buy | 19,230 | .52 | 9,999 |
| 2020-10-22 | Vitale Philip J (Director) | Buy | 20,000 | .52 | 10,400 |
| 2020-10-22 | Cavanagh William (Chief R&D Officer) | Buy | 7,692 | .52 | 3,999 |
| 2020-10-22 | Woods Lori A (CEO) | Buy | 48,076 | .52 | 24,999 |
| 2020-10-22 | Hunt Jonathan Robert (Chief Financial Officer) | Buy | 67,306 | .52 | 34,999 |
| 2020-10-22 | Mccormick Michael W (Director) | Buy | 19,230 | .52 | 9,999 |
| 2020-02-03 | Woods Lori A (CEO) | Option Ex | 262,500 | .50 | 130,725 |
| 2019-11-20 | Krachon Michael (VP of Sales & Marketing) | Buy | 50,000 | .39 | 19,500 |
| 2019-11-15 | Cavanagh William (Chief R&D Officer) | Buy | 10,000 | .39 | 3,900 |
| 2019-11-15 | Woods Lori A (CEO) | Buy | 25,000 | .39 | 9,750 |
| 2019-11-14 | Woods Lori A (CEO) | Buy | 125,000 | .40 | 49,500 |
| 2019-05-30 | Cline Krista (Dir. of Operations, Secretary) | Option Ex | 21,900 | .26 | 5,694 |
| 2018-11-20 | Hoffmann Alan (Director) | Buy | 25,000 | .40 | 10,000 |
| 2018-11-16 | Austin Mark John (Controller/Prin Fin&Acct Offic) | Buy | 4,283 | .40 | 1,704 |
| 2018-11-16 | Cavanagh William (COO, CSO) | Buy | 10,000 | .40 | 4,000 |
| 2018-11-15 | Woods Lori A (Interim CEO) | Buy | 5,000 | .40 | 1,990 |
| 2018-11-14 | Woods Lori A (Interim CEO) | Buy | 125,000 | .40 | 49,750 |
| 2018-11-13 | Austin Mark John (Controller/Prin Fin&Acct Offic) | Buy | 2,452 | .41 | 1,005 |
| 2018-11-13 | Vitale Philip J (Director) | Buy | 30,000 | .43 | 12,900 |
| 2018-03-14 | Vitale Philip J (Director) | Buy | 10,000 | .44 | 4,400 |
| 2018-03-01 | Lavoy Thomas C (CEO and Chairman of the Board) | Buy | 50,000 | .43 | 21,750 |
| 2017-11-24 | Austin Mark John (Controller/Prin Fin&Acct Offic) | Buy | 2,040 | .49 | 1,005 |
| 2017-11-22 | Austin Mark John (Controller/Prin Fin&Acct Offic) | Buy | 1,825 | .49 | 894 |
| 2017-11-21 | Austin Mark John (Controller/Prin Fin&Acct Offic) | Buy | 5,400 | .48 | 2,581 |
| 2017-11-20 | Krachon Michael (VP of Sales & Marketing) | Buy | 55,000 | .48 | 26,675 |
| 2017-11-20 | Lavoy Thomas C (CEO and Chairman of the Board) | Option Ex | 82,810 | .60 | 50,100 |
| 2017-11-16 | Vitale Philip J (Director) | Buy | 30,000 | .44 | 13,140 |
| 2017-03-10 | Lavoy Thomas C (CEO) | Buy | 20,000 | .53 | 10,600 |
| 2017-01-04 | Vitale Philip J (Director) | Buy | 20,000 | .66 | 13,160 |
| 2016-12-08 | Hoffmann Alan (Director) | Buy | 20,000 | .57 | 11,399 |
| 2016-11-17 | Lavoy Thomas C (CEO) | Buy | 20,000 | .60 | 12,000 |
| 2016-03-17 | Lavoy Thomas C (CEO) | Buy | 13,294 | .90 | 11,964 |
| 2016-03-11 | Vitale Philip J (Director) | Buy | 10,000 | .93 | 9,320 |
| 2016-03-11 | Lavoy Thomas C (CEO) | Buy | 36,706 | .89 | 32,668 |
| 2016-03-08 | Mccormick Michael W (Director) | Buy | 22,000 | .87 | 19,074 |
| 2015-11-12 | Babcock Dwight William (CEO) | Buy | 25,000 | 1.26 | 31,550 |
| 2015-06-09 | Babcock Dwight William (CEO) | Buy | 10,000 | 1.53 | 15,280 |
| 2015-04-02 | Cavanagh William (Vice President) | Sale | 13,340 | 1.53 | 20,410 |
| 2015-04-02 | Cavanagh William (Vice President) | Option Ex | 13,340 | .98 | 13,073 |
| 2015-03-06 | Lavoy Thomas C (Director) | Buy | 10,000 | 1.66 | 16,600 |
| 2015-03-05 | Vitale Philip J (Director) | Buy | 10,000 | 1.80 | 18,000 |
| 2015-03-03 | Babcock Dwight William (CEO) | Buy | 7,500 | 1.51 | 11,325 |
| 2015-03-02 | Babcock Dwight William (CEO) | Buy | 2,529 | 1.51 | 3,818 |
Insider trading activities including stock purchases, stock sales, and option exercises of CATX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Perspective Therapeutics, Inc. (symbol CATX, CIK number 728387) see the Securities and Exchange Commission (SEC) website.